{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:39:58Z","timestamp":1795066798914,"version":"4.10.2"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11335-1","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T11:58:42Z","timestamp":1753531122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Trends and patterns of antimicrobial resistance among common pathogens isolated from adult bloodstream and urinary tract infections in public health facilities in Malawi, 2020\u20132024"],"prefix":"10.1186","volume":"25","author":[{"given":"Akim N.","family":"Bwanali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano Focus","family":"Lubanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibongile","family":"Kondowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Nzima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Mwale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Watipaso","family":"Kamanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrispin","family":"Enerico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cresencia","family":"Masautso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandizo","family":"Kapatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steward","family":"Mudenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Mpinganjira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Mwale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Chitule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alinafe","family":"Kawerama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Chibwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collins","family":"Mitambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"11335_CR1","doi-asserted-by":"crossref","unstructured":"Yang X, Chen H, Zheng Y, Qu S, Wang H, Yi F. Disease burden and long-term trends of urinary tract infections: A worldwide report. Front Public Health. 2022;10. https:\/\/pubmed.ncbi.nlm.nih.gov\/35968451\/.","DOI":"10.3389\/fpubh.2022.888205"},{"issue":"3","key":"11335_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/jac\/dkz464","volume":"75","author":"R Lester","year":"2020","unstructured":"Lester R, Musicha P, Van Ginneken N, Dramowski A, Hamer DH, Garner P, et al. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: A systematic review. Journal of Antimicrobial Chemotherapy. 2020;75(3):492\u2013507.","journal-title":"Journal of Antimicrobial Chemotherapy."},{"issue":"11","key":"11335_CR3","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00345-019-03071-4","volume":"38","author":"R \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk R, Murt A. Epidemiology of urological infections: a global burden. World J Urol. 2020;38(11):2669\u201379.","journal-title":"World J Urol."},{"issue":"10325","key":"11335_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629\u201355.","journal-title":"The Lancet."},{"key":"11335_CR5","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.2147\/IDR.S234610","volume":"12","author":"P Dadgostar","year":"2019","unstructured":"Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903\u201310.","journal-title":"Infect Drug Resist."},{"issue":"2","key":"11335_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.idc.2016.02.001","volume":"30","author":"RR Watkins","year":"2016","unstructured":"Watkins RR, Bonomo RA. Overview: Global and Local Impact of Antibiotic Resistance. Infect Dis Clin North Am. 2016;30(2):313\u201322.","journal-title":"Infect Dis Clin North Am."},{"issue":"2","key":"11335_CR7","doi-asserted-by":"publisher","first-page":"e201","DOI":"10.1016\/S2214-109X(23)00539-9","volume":"12","author":"B Sartorius","year":"2024","unstructured":"Sartorius B, Gray AP, Davis Weaver N, Robles Aguilar G, Swetschinski LR, Ikuta KS, et al. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. Lancet Glob Health. 2024;12(2):e201-16.","journal-title":"Lancet Glob Health."},{"issue":"16","key":"11335_CR8","first-page":"27","volume":"16","author":"JB Ndihokubwayo","year":"2013","unstructured":"Ndihokubwayo JB, Yahaya AA, Desta AT, Ki-Zerbo G, Odei EA, Keita B, et al. Antimicrobial Resistance in the African Region: Issues, Challenges and Actions Proposed. WHO Office for African. 2013;16(16):27\u201330.","journal-title":"WHO Office for African."},{"key":"11335_CR9","unstructured":"\u00a0WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022. 2022;9:356\u201363. https:\/\/www.who.int\/publications\/i\/item\/9789240062702."},{"issue":"3","key":"11335_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/21505594.2016.1159366","volume":"7","author":"M Akova","year":"2016","unstructured":"Akova M. Epidemiology of antimicrobial resistance in bloodstream infections. Virulence. 2016;7(3):252\u201366.","journal-title":"Virulence."},{"issue":"1","key":"11335_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05725-w","volume":"21","author":"P Kumwenda","year":"2021","unstructured":"Kumwenda P, Adukwu EC, Tabe ES, Ujor VC, Kamudumuli PS, Ngwira M, et al. Prevalence, distribution and antimicrobial susceptibility pattern of bacterial isolates from a tertiary Hospital in Malawi. BMC Infect Dis. 2021;21(1):1\u201310.","journal-title":"BMC Infect Dis."},{"issue":"3","key":"11335_CR12","first-page":"229","volume":"7","author":"J Mbanga","year":"2010","unstructured":"Mbanga J, Dube S, Munyanduki H. Prevalence and drug resistance in bacteria of the urinary tract infections in Bulawayo province. Zimbabwe East Afr J Public Health. 2010;7(3):229\u201332.","journal-title":"Zimbabwe. East Afr J Public Health."},{"issue":"March","key":"11335_CR13","doi-asserted-by":"publisher","first-page":"100081","DOI":"10.1016\/j.glmedi.2024.100081","volume":"2","author":"SK Ahmed","year":"2024","unstructured":"Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmood KA, et al. Antimicrobial resistance: Impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health. 2024;2(March):100081.","journal-title":"Journal of Medicine, Surgery, and Public Health."},{"issue":"9","key":"11335_CR14","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/jac\/dku176","volume":"69","author":"SJ Leopold","year":"2014","unstructured":"Leopold SJ, van Leth F, Tarekegn H, Schultsz C. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. Journal of Antimicrobial Chemotherapy. 2014;69(9):2337\u201353.","journal-title":"Journal of Antimicrobial Chemotherapy."},{"issue":"1","key":"11335_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2713-1","volume":"17","author":"BT Tadesse","year":"2017","unstructured":"Tadesse BT, Ashley EA, Ongarello S, Havumaki J, Wijegoonewardena M, Gonz\u00e1lez IJ, et al. Antimicrobial resistance in Africa: A systematic review. BMC Infect Dis. 2017;17(1):1\u201317.","journal-title":"BMC Infect Dis."},{"issue":"10","key":"11335_CR16","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S1473-3099(17)30394-8","volume":"17","author":"P Musicha","year":"2017","unstructured":"Musicha P, Cornick JE, Bar-Zeev N, French N, Masesa C, Denis B, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998\u20132016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042\u201352.","journal-title":"Lancet Infect Dis."},{"key":"11335_CR17","unstructured":"World Health Organization(WHO). Global report on health data systems and capacity, 2020. Jo Chemical Information and Modeling. 2020;10:1\u201313. https:\/\/iris.who.int\/bitstream\/handle\/10665\/339125\/9789240018709-eng.pdf."},{"key":"11335_CR18","unstructured":"Fleming Fund PII underway in Malawi: African leadership to address deadly AMR| Fleming Fund. Available from: https:\/\/www.flemingfund.org\/publications\/fleming-fund-second-phase-underway-in-malawi-african-leadership-to-address-deadly-amr\/. Cited 24 Jan 2025."},{"key":"11335_CR19","unstructured":"Grant boosts antimicrobial resistance efforts in Malawi| Institute for Global Health and Infectious Diseases. Available from: https:\/\/globalhealth.unc.edu\/2020\/02\/grant-boosts-antimicrobial-resistance-efforts-in-malawi\/. Cited 24 Jan 2025."},{"issue":"June","key":"11335_CR20","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.2147\/IDR.S342753","volume":"15","author":"S Kariuki","year":"2022","unstructured":"Kariuki S, Kering K, Wairimu C, Onsare R, Mbae C. Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now? Infect Drug Resist. 2022;15(June):3589\u2013609.","journal-title":"Infect Drug Resist."},{"issue":"6","key":"11335_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1473-3099(10)70072-4","volume":"10","author":"EA Reddy","year":"2010","unstructured":"Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(6):417\u201332.","journal-title":"Lancet Infect Dis."},{"issue":"8","key":"11335_CR22","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1080\/14740338.2022.2106368","volume":"21","author":"B Godman","year":"2022","unstructured":"Godman B, Egwuenu A, Wesangula E, Schellack N, Kalungia AC, Tiroyakgosi C, et al. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future. Expert Opin Drug Saf. 2022;21(8):1089\u2013111.","journal-title":"Expert Opin Drug Saf."},{"key":"11335_CR23","doi-asserted-by":"publisher","unstructured":"Mhondoro M, Ndlovu N, Donewell B, Juru T, Tafara GN. Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012\u20132017: a secondary dataset analysis. 2019;6:1\u20139. https:\/\/doi.org\/10.1186\/s12879-019-4295-6","DOI":"10.1186\/s12879-019-4295-6"},{"key":"11335_CR24","doi-asserted-by":"publisher","unstructured":"Elton L, Thomason MJ, Tembo J, Velavan TP, Pallerla SR, Arruda LB, et al. Antimicrobial resistance preparedness in sub-Saharan African countries. 2020;1\u201311. https:\/\/doi.org\/10.1186\/s13756-020-00800-y.","DOI":"10.1186\/s13756-020-00800-y"},{"key":"11335_CR25","unstructured":"EUCAST. \u201cThe European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, 2024. https:\/\/www.eucast.org."},{"issue":"2","key":"11335_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4314\/ahs.v21i2.4","volume":"21","author":"KC Mofolorunsho","year":"2021","unstructured":"Mofolorunsho KC, Ocheni HO, Aminu RF, Omatola CA, Olowonibi OO. Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing escherichia coli and klebsiella pneumoniae isolated in selected hospitals of anyigba. Nigeria Afr Health Sci. 2021;21(2):505\u201312.","journal-title":"Nigeria. Afr Health Sci."},{"issue":"04","key":"11335_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4236\/ojmm.2015.54022","volume":"05","author":"A Shatalov","year":"2015","unstructured":"Shatalov A. Prevalence and Antibiotic Resistance Pattern of Escherichia coli and Klebsiella pneumoniae in Urine Tract Infections at the La Paz Medical Center, Malabo. Equatorial Guinea Open J Med Microbiol. 2015;05(04):177\u201383.","journal-title":"Equatorial Guinea. Open J Med Microbiol."},{"issue":"4","key":"11335_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1542\/pir.36.4.167","volume":"36","author":"S Makvana","year":"2015","unstructured":"Makvana S, Krilov LR. Escherichia coli Infections. Pediatr Rev. 2015;36(4):167\u201371.","journal-title":"Pediatr Rev."},{"issue":"02","key":"11335_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1055\/s-0040-1716478","volume":"12","author":"P Venkataramana Geetha","year":"2020","unstructured":"Venkataramana Geetha P, Vijaya K, Aishwarya L, Mariappan S, Sekar U. Fluoroquinolone Resistance in Clinical Isolates of Klebsiella Pneumoniae. J Lab Physicians. 2020;12(02):121\u20135.","journal-title":"J Lab Physicians."},{"issue":"2","key":"11335_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/femsre\/fuy043","volume":"43","author":"JA Bengoechea","year":"2019","unstructured":"Bengoechea JA, Sa Pessoa J. Klebsiella pneumoniae infection biology: Living to counteract host defences. FEMS Microbiol Rev. 2019;43(2):123\u201344.","journal-title":"FEMS Microbiol Rev."},{"issue":"12","key":"11335_CR31","doi-asserted-by":"publisher","first-page":"e922","DOI":"10.1016\/S2666-5247(22)00282-8","volume":"3","author":"R Lester","year":"2022","unstructured":"Lester R, Musicha P, Kawaza K, Langton J, Mango J, Mangochi H, et al. Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study. Lancet Microbe. 2022;3(12):e922-30.","journal-title":"Lancet Microbe."},{"issue":"4","key":"11335_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.14252\/foodsafetyfscj.2017011","volume":"5","author":"K Kawamura","year":"2017","unstructured":"Kawamura K, Nagano N, Suzuki M, Wachino J, Kimura K, Arakawa Y. ESBL-producing Escherichia coli and Its Rapid Rise among Healthy People. Food Safety. 2017;5(4):122\u201350.","journal-title":"Food Safety."},{"issue":"1","key":"11335_CR33","first-page":"45","volume":"48","author":"B Duttaroy","year":"2005","unstructured":"Duttaroy B, Mehta S. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Indian J Pathol Microbiol. 2005;48(1):45\u20138.","journal-title":"Indian J Pathol Microbiol."},{"key":"11335_CR34","doi-asserted-by":"publisher","unstructured":"Onduru OG, Mkakosya RS, Aboud S, Rumisha SF. Genetic Determinants of Resistance among ESBL-Producing Enterobacteriaceae in Community and Hospital Settings in East, Central, and Southern Africa: A Systematic Review and Meta-Analysis of Prevalence. Canadian Journal of Infectious Diseases and Medical Microbiology. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/5153237.","DOI":"10.1155\/2021\/5153237"},{"key":"11335_CR35","doi-asserted-by":"publisher","unstructured":"Kasanga M, Gajd\u00e1cs M, Muleya W, Ikhimiukor OO, Mudenda S, Kasanga M, et al. Genotypic Characterisation and Antimicrobial Resistance of Extended-Spectrum \u03b2-Lactamase-Producing Escherichia coli in Humans, Animals, and the Environment from Lusaka, Zambia: Public Health Implications and One Health Surveillance. Antibiotics. 2024;13(10). https:\/\/doi.org\/10.3390\/antibiotics13100951.","DOI":"10.3390\/antibiotics13100951"},{"issue":"8","key":"11335_CR36","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.cmi.2019.03.030","volume":"25","author":"B Guti\u00e9rrez-Guti\u00e9rrez","year":"2019","unstructured":"Guti\u00e9rrez-Guti\u00e9rrez B, Rodr\u00edguez-Ba\u00f1o J. Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients. Clinical Microbiology and Infection. 2019;25(8):932\u201342.","journal-title":"Clinical Microbiology and Infection."},{"key":"11335_CR37","unstructured":"Who. WHO bacterial priority pathogens list, 2024. Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. 2024:72. https:\/\/www.who.int\/publications\/i\/item\/9789240093461."},{"key":"11335_CR38","doi-asserted-by":"publisher","unstructured":"Mandujano-Hern\u00e1ndez A, Mart\u00ednez-V\u00e1zquez AV, Paz-Gonz\u00e1lez AD, Herrera-Mayorga V, S\u00e1nchez-S\u00e1nchez M, Lara-Ram\u00edrez EE, et al. The Global Rise of ESBL-Producing Escherichia coli in the Livestock Sector: A Five-Year Overview. Animals. 2024;14(17). https:\/\/doi.org\/10.3390\/ani14172490.","DOI":"10.3390\/ani14172490"},{"key":"11335_CR39","unstructured":"Ministry of Health of Malawi. Malawi standard treatment guidelines\u2014incorporating Malawi essential medicines list. 2015. p 638."},{"key":"11335_CR40","doi-asserted-by":"crossref","unstructured":"Arivazhahan A. Sulfonamides, Quinolones, and Agents for Urinary Tract Infections. In: Paul Abialbon and Anandabaskar N and MJ and RGM, editor. Introduction to Basics of Pharmacology and Toxicology: Volume 2: Essentials of Systemic Pharmacology: From Principles to Practice. Singapore: Springer Nature Singapore; 2021. p. 807\u201319.","DOI":"10.1007\/978-981-33-6009-9_53"},{"issue":"1","key":"11335_CR41","first-page":"21","volume":"20","author":"P Vachvanichsanong","year":"2007","unstructured":"Vachvanichsanong P. Urinary tract infection: One lingering effect of childhood kidney diseases - Review of the literature. J Nephrol. 2007;20(1):21\u20138.","journal-title":"J Nephrol."},{"key":"11335_CR42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2147\/IJGM.S223882","volume":"12","author":"OO Oleribe","year":"2019","unstructured":"Oleribe OO, Momoh J, Uzochukwu BSC, Mbofana F, Adebiyi A, Barbera T, et al. Identifying key challenges facing healthcare systems in Africa and potential solutions. Int J Gen Med. 2019;12:395\u2013403.","journal-title":"Int J Gen Med."},{"issue":"1","key":"11335_CR43","first-page":"1","volume":"14","author":"AN Bwanali","year":"2024","unstructured":"Bwanali AN, Munthali L, Napolo U, Lubanga AF, Gundo R, Mpinganjira SL. Clinical audit of cases and outcomes of patients admitted to the intensive care unit at Kamuzu Central Hospital, Lilongwe. Malawi Sci Rep. 2024;14(1):1\u20137.","journal-title":"Malawi. Sci Rep."},{"key":"11335_CR44","unstructured":"WHO Afro. Antimicrobial Resistance in the Who African Region: WHO Regional Office for Africa. 2021. p 1\u201361. https:\/\/www.afro.who.int\/sites\/default\/files\/2021-11\/Antimicrobial%20Resistance%20in%20the%20WHO%20African%20region%20a%20systematic%20literature%20review.pdf."},{"key":"11335_CR45","doi-asserted-by":"publisher","unstructured":"Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: A systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015;15(1). https:\/\/doi.org\/10.1186\/s12879-015-1282-4.","DOI":"10.1186\/s12879-015-1282-4"},{"key":"11335_CR46","unstructured":"The Ministry of Health Malawi. Malawi Standard Treatment Guidelines (MSTG) 5th Edition 2015 Guidelines. 2015;687. https:\/\/extranet.who.int\/ncdccs\/Data\/MWI_D1_Malawi-Standard-Treatment-Guidelines-Essential-Medicines-List-2015.pdf."},{"key":"11335_CR47","doi-asserted-by":"publisher","unstructured":"Shariati A, Arshadi M, Khosrojerdi MA, Abedinzadeh M, Ganjalishahi M, Maleki A, et al. The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Front Public Health. 2022;10. https:\/\/doi.org\/10.3389\/fpubh.2022.1025633.","DOI":"10.3389\/fpubh.2022.1025633"},{"key":"11335_CR48","doi-asserted-by":"publisher","unstructured":"Chang MX, Zhang JF, Sun YH, Li RS, Lin XL, Yang L, et al. Contribution of Different Mechanisms to Ciprofloxacin Resistance in Salmonella spp. Front Microbiol. 2021;12(May). https:\/\/doi.org\/10.3389\/fmicb.2021.663731.","DOI":"10.3389\/fmicb.2021.663731"},{"key":"11335_CR49","doi-asserted-by":"crossref","unstructured":"Aminu A, Daneji IM, Yusuf MA, Jalo RI, Tsiga-Ahmed FI, Yahaya M, et al. Carbapenem-resistant Enterobacteriaceae infections among patients admitted to intensive care units in Kano, Nigeria. Sahel Medical Journal. 2021;24(1). https:\/\/www.researchgate.net\/publication\/350950098_Carbapenem-resistant_Enterobacteriaceae_infections_among_patients_admitted_to_intensive_care_units_in_Kano_Nigeria.","DOI":"10.4103\/smj.smj_14_20"},{"key":"11335_CR50","doi-asserted-by":"publisher","unstructured":"Gobezie MY, Hassen M, Tesfaye NA, Solomon T, Demessie MB, Kassa TD, et al. Prevalence of meropenem-resistant Pseudomonas Aeruginosa in Ethiopia: a systematic review and metaanalysis. Vol. 13, Antimicrobial Resistance and Infection Control. BioMed Central Ltd; 2024. https:\/\/doi.org\/10.1186\/s13756-024-01389-2.","DOI":"10.1186\/s13756-024-01389-2"},{"issue":"10","key":"11335_CR51","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S1473-3099(20)30854-9","volume":"21","author":"I Adekoya","year":"2021","unstructured":"Adekoya I, Maraj D, Steiner L, Yaphe H, Moja L, Magrini N, et al. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study. Lancet Infect Dis. 2021;21(10):1429\u201340.","journal-title":"Lancet Infect Dis."},{"issue":"11","key":"11335_CR52","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1016\/S2214-109X(17)30365-0","volume":"5","author":"P McGettigan","year":"2017","unstructured":"McGettigan P, Roderick P, Kadam A, Pollock AM. Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship. Lancet Glob Health. 2017;5(11):e1075-6.","journal-title":"Lancet Glob Health."},{"issue":"5","key":"11335_CR53","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4269\/ajtmh.12-0642","volume":"89","author":"N Obeng-Nkrumah","year":"2013","unstructured":"Obeng-Nkrumah N, Twum-Danso K, Krogfelt KA, Newman MJ. High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana: The need for regular monitoring and evaluation of antibiotic resistance. American Journal of Tropical Medicine and Hygiene. 2013;89(5):960\u20134.","journal-title":"American Journal of Tropical Medicine and Hygiene."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11335-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11335-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11335-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:33:19Z","timestamp":1757295199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11335-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11335"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11335-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval to conduct the study was obtained from the National Health Science Research Committee (NHSRC) (Approval number 23\/11\/4048). We sought permission to evaluate the data from the Public Health Institute of Malawi (a directorate under the Ministry of Health), the NMRL, and health facilities from which the data originated. Informed consent forms for participants were not necessary since the data was not obtained directly from patients and the data did not involve interventions or interactions with patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"946"}}